ASTRO 2022 | Challenges and unmet needs of treating patients with hepatocellular carcinoma with radiotherapy

Alejandra Mendez Romero, MD, PhD, Erasmus MC Cancer Institute, Rotterdam, Netherlands, discusses the difficulties of finding the balance between killing a liver cancer tumor and preserving liver function, when treating patients with hepatocellular carcinoma with radiotherapy. Dr Romero also emphasises the need for more data to support future guidelines in this field, along with the importance of improving worldwide access to radiotherapy. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.